Artificial intelligence (AI) software developer RapidAI has launched its Rapid Technology Partner Program, as well as a new application programming interface (API) for its AI stroke detection software.
The partner program will serve as an ecosystem of technologies that complement or integrate with the Rapid platform, while the new API will enable technology partners to integrate Rapid results into their products and services, according to the company.
Current members of the RapidAI Technology Partner Program include Allm, Ambra Health, Halo Communications, Mobile Heartbeat, Pulsara, Samsung Neurologica, Siemens Healthineers, Spok, and TigerConnect.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
